O
ORIC PHARMACEUTICALS INC
NASDAQ: ORIC (Oric Pharmaceuticals, Inc.)
最近更新时间: 52分钟之前11.39
0.41 (3.73%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 混合的 |
| Biotechnology (全球的) | 混合的 | 混合的 | |
| 股票 | Oric Pharmaceuticals, Inc. | 看涨 | 看跌 |
AIStockmoo 评分
0.4
| 分析师共识 | 4.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.38 |
|
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 7.93% |
| 机构持股比例 | 102.70% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Nextech Invest, Ltd. | 30 Sep 2025 | 7,162,637 |
| Nextech Invest Ltd. | 31 Dec 2024 | 5,285,714 |
| Column Group Llc | 30 Sep 2025 | 3,540,777 |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 25.00 (Evercore ISI Group, 119.49%) | 购买 |
| 中 | 19.50 (71.20%) | |
| 低 | 15.00 (Oppenheimer, 31.69%) | 购买 |
| 平均值 | 19.67 (72.70%) | |
| 总计 | 6 购买 | |
| 平均价格@调整类型 | 12.03 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| Evercore ISI Group | 20 Nov 2025 | 25.00 (119.49%) | 购买 | 11.48 |
| JP Morgan | 18 Nov 2025 | 20.00 (75.59%) | 购买 | 11.90 |
| Citigroup | 17 Nov 2025 | 16.00 (40.47%) | 购买 | 12.06 |
| HC Wainwright & Co. | 14 Nov 2025 | 23.00 (101.93%) | 购买 | 12.25 |
| Oppenheimer | 14 Nov 2025 | 15.00 (31.69%) | 购买 | 12.25 |
| Wells Fargo | 14 Nov 2025 | 19.00 (66.81%) | 购买 | 12.25 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合